查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1302444

基於細胞的檢測市場：按產品、按用途、按最終用戶 - 2023-2030 年全球預測

Cell-based Assay Market by Offerings (Consumables, Instruments, Services), Application (Basic Research, Drug Discovery), End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年全球細胞檢測市場規模將達166.3億美元，複合年成長率為7.42%，大幅成長，2030年將達275億美元。

FPNV定位矩陣

FPNV 定位矩陣對於評估全球細胞檢測市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.細胞檢測的全球市場規模和預測是多少？

2.在預測期內，COVID-19 對全球細胞檢測市場的阻礙因素與影響有哪些？

3. 在預測期內，全球細胞分析市場需要投資哪些產品/細分市場/用途/領域？

4. 你們在全球細胞檢測市場的競爭策略是什麼？

5. 全球細胞檢測市場的技術趨勢和法律規範是什麼？

6. 全球細胞檢測市場主要供應商的市佔率為何？

7. 哪些型態和策略措施被認為適合進入全球細胞檢測市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 心血管疾病、感染疾病、糖尿病和癌症的全球盛行率
      • 了解基於細胞的檢測相對於傳統治療方法的優勢
      • 全球對新藥和治療方法的需求不斷成長
    • 抑制因素
      • 熟練專業人員數量有限
    • 機會
      • 在各種超高通量篩選中擴大使用基於細胞的測定
      • 基於細胞分析的體外藥物研究數量不斷增加
    • 任務
      • 不利的法律規範
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 基於細胞的檢測市場：透過提供

  • 消耗品
    • 檢測試劑盒
    • 細胞株
    • 微孔板
    • 探針和標籤
    • 試劑
  • 裝置
  • 服務

第7章 基於細胞的檢測市場：依用途

  • 基礎研究
  • 藥物研發
    • 藥效研究
    • 藥物動力學研究
    • 毒性研究

第8章 基於細胞的檢測市場：依最終用戶分類

  • 學術機構/政府機構
  • 受託研究機構
  • 製藥和生物技術公司

第9章 美洲細胞檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太細胞分析市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲/中東/非洲細胞檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析：主要企業
  • 競爭情境分析：主要企業

第13章上市公司名單

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-436B79517C47

The Global Cell-based Assay Market is forecasted to grow significantly, with a projected USD 16.63 billion in 2023 at a CAGR of 7.42% and expected to reach a staggering USD 27.50 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Cell-based Assay Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Cell-based Assay Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Offerings, market is studied across Consumables, Instruments, and Services. The Consumables is further studied across Assay Kits, Cell Lines, Microplates, Probes & Labels, and Reagents. The Instruments is projected to witness significant market share during forecast period.

Based on Application, market is studied across Basic Research and Drug Discovery. The Drug Discovery is further studied across Pharmacodynamic Studies, Pharmacokinetic Studies, and Toxicity Studies. The Drug Discovery is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Academic & Government Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies. The Academic & Government Institutes is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Cell-based Assay Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Cell-based Assay Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell-based Assay Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell-based Assay Market?

4. What is the competitive strategic window for opportunities in the Global Cell-based Assay Market?

5. What are the technology trends and regulatory frameworks in the Global Cell-based Assay Market?

6. What is the market share of the leading vendors in the Global Cell-based Assay Market?

7. What modes and strategic moves are considered suitable for entering the Global Cell-based Assay Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cell-based Assay Market, by Offerings, 2022 vs 2030
  • 4.3. Cell-based Assay Market, by Application, 2022 vs 2030
  • 4.4. Cell-based Assay Market, by End-User, 2022 vs 2030
  • 4.5. Cell-based Assay Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of cardiovascular & infectious disease, diabetes, and cancer worldwide
      • 5.1.1.2. Awareness regarding advantages of cell-based assays over traditional treatments
      • 5.1.1.3. Rising worldwide demand for novel drugs and treatments
    • 5.1.2. Restraints
      • 5.1.2.1. Limited skilled professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising use of cell-based assays in various ultra-high throughput screening
      • 5.1.3.2. Growing number of in-vitro drug studies based on cell-based assays
    • 5.1.4. Challenges
      • 5.1.4.1. Unfavorable regulatory framework
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Cell-based Assay Market, by Offerings

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.2.1. Assay Kits
    • 6.2.2. Cell Lines
    • 6.2.3. Microplates
    • 6.2.4. Probes & Labels
    • 6.2.5. Reagents
  • 6.3. Instruments
  • 6.4. Services

7. Cell-based Assay Market, by Application

  • 7.1. Introduction
  • 7.2. Basic Research
  • 7.3. Drug Discovery
    • 7.3.1. Pharmacodynamic Studies
    • 7.3.2. Pharmacokinetic Studies
    • 7.3.3. Toxicity Studies

8. Cell-based Assay Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Government Institutes
  • 8.3. Contract Research Organizations
  • 8.4. Pharmaceutical & Biotechnology Companies

9. Americas Cell-based Assay Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cell-based Assay Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cell-based Assay Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. CELL-BASED ASSAY MARKET RESEARCH PROCESS
  • FIGURE 2. CELL-BASED ASSAY MARKET SIZE, 2022 VS 2030
  • FIGURE 3. CELL-BASED ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2022 VS 2030 (%)
  • FIGURE 5. CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 7. CELL-BASED ASSAY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. CELL-BASED ASSAY MARKET DYNAMICS
  • FIGURE 9. CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. CELL-BASED ASSAY MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. CELL-BASED ASSAY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. CELL-BASED ASSAY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. CELL-BASED ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 5. CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 6. CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CELL-BASED ASSAY MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. CELL-BASED ASSAY MARKET SIZE, BY CELL LINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. CELL-BASED ASSAY MARKET SIZE, BY MICROPLATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. CELL-BASED ASSAY MARKET SIZE, BY PROBES & LABELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. CELL-BASED ASSAY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. CELL-BASED ASSAY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. CELL-BASED ASSAY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. CELL-BASED ASSAY MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 17. CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. CELL-BASED ASSAY MARKET SIZE, BY PHARMACODYNAMIC STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. CELL-BASED ASSAY MARKET SIZE, BY PHARMACOKINETIC STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. CELL-BASED ASSAY MARKET SIZE, BY TOXICITY STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. CELL-BASED ASSAY MARKET SIZE, BY ACADEMIC & GOVERNMENT INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. CELL-BASED ASSAY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. CELL-BASED ASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. CELL-BASED ASSAY MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 235. CELL-BASED ASSAY MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 236. CELL-BASED ASSAY MARKET LICENSE & PRICING